We are pleased to announce that our CEO, Jan Hendriks, will be representing our company at the highly anticipated BIO CEO & Investor Conference in New York City on February 27-28! The BIO CEO & Investor Conference is renowned for bringing together top-tier investors, industry analysts, and senior biotech leaders to discuss the latest trends […]

We are thrilled to announce our active participation in the upcoming 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) Tech Fair, scheduled to take place in Florence from 6th to 9th March 2024. Exhibition Booth: Visit us at our exhibition booth [#20] throughout the event where we’ll showcase our cutting-edge innovations in […]

Jan Hendriks, CEO of Biotts, will be at JPM Week 2024, and he’s eager to connect with investors interested in our revolutionary, patented transdermal drug delivery technology. Don’t miss the chance to explore partnership opportunities and discuss the future of drug delivery! Schedule a meeting with Jan via Bio Partnering platform (click the link below) […]

We are pleased to share the news of our strategic collaboration with BIOTON S.A. Together, we embark on a groundbreaking proof-of-concept project aimed at transdermal insulin delivery – a pioneering initiative set to make history. BIOTON, the world’s top eight commercial manufacturers of recombinant human insulin, provides patients with safe and complete solutions for diabetes […]

Join us at BioEurope 2023 in Munich! We’re thrilled to extend a warm invitation to you for our exclusive presentation on November 6th at 3:30 pm. Don’t miss the opportunity to discover the boundless potential of our patented MTC-Y technology. Explore our recent achievements in notable projects, including transdermal semaglutide and insulin. Save the date! […]